Dr. Subhabrata Kar

About

Dr. Subhabarat Kar is currently Associate Professor in Department of Life Sciences. Dr. Kar has completed his M.Sc. in Biochemistry from C.C.S. University, U.P. and his Ph.D in Biotechnology from National Institute of Pharmaceutical Education & Research (NIPER), Mohali. He has more than 10 years of teaching and research experience. He has published his research in international peer-reviewed journals and has presented his work at various national and international conferences. Dr. Kar is a dedicated and passionate teacher with a strong commitment to research and innovation. Currently Dr. Kar is conducting 01 external research project funded by DBT. Dr. Kar has also served as a reviewer in international journals, and has many national and international research collaborations.

Experience

• 10 years

Qualification

• PhD Biotechnology
• MSc Biochemistry
   

Award & Recognition

• 7

Research

• M. A. Kausar, A. M. Rabie, F. Azam, S. Anwar, F. Alenazi, K. F. Alshammari, S. Kar et.al., The role of Aedes aegypti in inducing/aggravating IgE-mediated allergic airway disease: extensive computational studies for identification of allergenic proteins, Journal of Biomolecular Structure and Dynamics (2023). Accepted. D.O.I.
• Impact Factor: 5.2.
• M. A. Kausar, S. Anwar, W.A. Eltayb, M. Kuddus, F. Khatoon, A.A. El-Arabey, A.M. Khalifa, M.R. Rizvi, M.Z. Najm, L. Thakur, S. Kar; et.al., MD Simulation Studies for Selective Phytochemicals as Potential Inhibitors against Major Biological Targets of Diabetic Nephropathy, Molecules, 27 (2022) 1-11. D.O.I.
• Impact Factor: 4.97
• M. Sinha, U. Chakraborty, A. Kool, M. Chakravarty, S. Das, S. Ghosh, L. Thakur, A. Khuranna, D. Nayak, B. Basu, S. Kar, R. Ray, S. Das, In-vitro antiviral action of Eupatorium Perfoliatum against dengue virus infection: modulation of mTOR signaling and autophagy, J Ethnopharmacology, 282 (2022) 1-12. PMID: 34509603
• Impact Factor: 5.2
• D. Konar, S. Maru, S. Kar, K. Kumar, Synthesis and Clinical Development of Palbociclib: An overview, Med Chem, 17 (2021) 1-27. PMID: 33280599
• Impact Factor: 2.33
• N. Sadaf, V. Shingatgeri, M. Uddin, M.A. Izhari, M.S. Akhtar, A. Kathait, S. Kar, S., I. Jain, P. Datt, K. Komal, A. Sharma, The Pivotal Role of Senescence in Cell Death and Aging: Where Do We Stand?, Curr Mol Bio Rep, 6 (2020) 91-101. D.O.I.
• S. Kar, M.A. Patel, R.K. Tripathy, P. Bajaj, A.H. Pande, Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1, Biochim Biophys Acta, 1831 (2013) 1714-1720. PMID: 23973798
• S. Kar, P. Bajaj, R.K. Tripathy, A.H. Pande, The chemical nature of the polar functional group of oxidized acyl chain uniquely modifies the physicochemical properties of oxidized phospholipid-containing lipid particles, J Membr Bio, 246 (2013) 443-452. PMID: 23673722
• S. Kar, M.A. Patel, R.K. Tripathy, P. Bajaj, U.V. Suvarnakar, A.H. Pande, Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function, Biochim Biophys Acta, 1821 (2012) 1200-1210. PMID: 22634518
• S. Kar, V.A. Tillu, S.C. Meena, A.H. Pande, Closely related oxidized phospholipids differentially modulate the physicochemical properties of lipid particles, Chem Phys Lipids, 164 (2011) 54-61. PMID: 21074521
• A.H. Pande, S. Kar, R.K. Tripathy, Oxidatively modified fatty acyl chain determines physicochemical properties of aggregates of oxidized phospholipids, Biochim Biophys Acta, 1798 (2010) 442-452. PMID: 20060379

Patents:

• S. Kar. Novel Hybrid Tryptanthrin Method Based Topoisomerase Inhibitors. (Application No. 202211031057 A) Filed in 2022.

Research Grant: DBT

• A study on nanoformulations of Bacopa monnieri active components targeting Glioblastoma and associated Neurocognitive Dysfunction
• Co-Principal Investigator 21.6L 2023 – 2026

Certifications

• 15

Area of Interest

• Protein Biochemistry
• Recombinant protein biopharmaceuticals